Trial in Progress of Engot-Cx8/Gog-3024/Innovatv 205: Addition of A New Cohort Using First-Line Tisotumab Vedotin Plus Pembrolizumab Plus Carboplatin +/- Bevacizumab in Recurrent/Metastatic Cervical Cancer
| dc.contributor.author | Vergote, Ignace | |
| dc.contributor.author | Mirza, Mansoor | |
| dc.contributor.author | Sehouli, Jalid | |
| dc.contributor.author | Lorusso, Domenica | |
| dc.contributor.author | Kose, Fatih | |
| dc.contributor.author | Cibula, David | |
| dc.contributor.author | Westermann, Anneke | |
| dc.contributor.author | Collins, Dearbhaile | |
| dc.contributor.author | Banerjee, Susana | |
| dc.contributor.author | Oaknin, Ana | |
| dc.contributor.author | Soumaoro, Ibrahima | |
| dc.contributor.author | Jain, Shweta | |
| dc.contributor.author | Monk, Bradley | |
| dc.date.accessioned | 2023-09-14T10:55:38Z | |
| dc.date.available | 2023-09-14T10:55:38Z | |
| dc.date.issued | 2022 | |
| dc.identifier.eissn | 1525-1438 | en_US |
| dc.identifier.endpage | A225 | en_US |
| dc.identifier.issn | 1048-891X | en_US |
| dc.identifier.issue | Supplement 3 | en_US |
| dc.identifier.startpage | A225 | en_US |
| dc.identifier.uri | https://ijgc.bmj.com/content/ijgc/32/Suppl_3/A225.1.full.pdf | |
| dc.identifier.uri | http://hdl.handle.net/11727/10659 | |
| dc.identifier.volume | 32 | en_US |
| dc.identifier.wos | 000899252300469 | en_US |
| dc.language.iso | eng | en_US |
| dc.relation.isversionof | 10.1136/ijgc-2022-igcs.513 | en_US |
| dc.relation.journal | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | Trial in Progress of Engot-Cx8/Gog-3024/Innovatv 205: Addition of A New Cohort Using First-Line Tisotumab Vedotin Plus Pembrolizumab Plus Carboplatin +/- Bevacizumab in Recurrent/Metastatic Cervical Cancer | en_US |
| dc.type | Conference Object | en_US |